Latest Articles

  • Should patients with gout avoid
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 83-86; DOI: https://doi.org/10.3949/ccjm.81a.13131

    No study has directly addressed this issue. In most cases, continue the thiazide and adjust the hypouricemic therapy if necessary.

  • The impact of anti-TNF therapy on the nonspecialist
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 71-72; DOI: https://doi.org/10.3949/ccjm.81b.02014

    These drugs are being used in a growing number of diseases. We all need to increase our familiarity with their unique risks.

  • In Reply: Canagliflozin (November 2013)
    Mary Vouyiouklis, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 90; DOI: https://doi.org/10.3949/ccjm.81c.02005
  • Reviewers 2013
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 102;
  • Managing risks of TNF inhibitors: An update for the internist
    Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.81a.12121

    Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

  • Canagliflozin (November 2013)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 88-90; DOI: https://doi.org/10.3949/ccjm.81c.02004
  • In Reply: Stiff, numb hands (June 2013)
    Khaldoon Shaheen, MD and Srinivas Merugu, MD, MMM
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87; DOI: https://doi.org/10.3949/ccjm.81c.02002

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • Stiff, numb hands (June 2013)
    Morton H. Field, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87; DOI: https://doi.org/10.3949/ccjm.81c.02001

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • Canagliflozin (November 2013)
    René Rodríguez-Gutiérrez, MD and Gloria Gonzalez-Saldivar, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87-88; DOI: https://doi.org/10.3949/ccjm.81c.02003

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • Wide QRS complex rhythm with pulseless electrical activity
    Laszlo Littmann, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 81-82; DOI: https://doi.org/10.3949/ccjm.81a.13079

    Although this presentation is grave, several of its possible causes can be treated, allowing the patient to recover.

Pages